An Open Label Study to Assess the Effect of a Combination of Avastin and Docetaxel and Sequential Chemotherapy on Pathological Response in Patients With Primary Operable HER2 Negative Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 15 Mar 2011 Actual end date changed from Nov 2010 to Mar 2011 as reported by ClinicalTrials.gov.
- 18 Jan 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.